Outpatient Clinic â€“ Month 4: BK suppressed, stable function, vaccinations and ongoing prophylaxis

Patient: Noah Patel
Date: 2025-09-23
Encounter: Post-transplant follow-up, Month 4

Interval History:
Patient presents with parents for 4-month follow-up. No fevers, urinary symptoms, or GI upset. Parents report excellent adherence to medication schedule. Patient received influenza vaccination at this visit. Energy and appetite good. No school absences.

Medications:
- Tacrolimus 0.07 mg/kg BID
- MMF reduced dose 450 mg/m2 BID (adjusted for BK viremia)
- Prednisone 5 mg daily
- Valganciclovir (CMV prophylaxis, D+/R-)
- TMP-SMX (PCP prophylaxis)

Vitals:
BP 108/72, HR 80, afebrile.

Physical Exam:
Well-appearing. Incision fully healed. No tenderness over graft. No edema. Normal cardiovascular and pulmonary exam.

Labs:
- Creatinine 1.0 mg/dL
- Tacrolimus trough 7.9 ng/mL (goal range)
- CBC stable
- Electrolytes normal
- BK PCR: <500 copies/mL (not detected)
- CMV PCR: negative
- EBV PCR: negative

Assessment/Plan:
Month 4 follow-up. Graft function remains excellent. BK viremia has resolved with MMF dose reduction. Continue tacrolimus, reduced MMF, prednisone, and prophylaxis. Influenza vaccine administered. Plan to continue valganciclovir for total of 6 months post-transplant given D+/R- status. RTC in 4 weeks with labs and viral PCRs.
